In silico study of β-carboline alkaloids as Acetylcholinesterase Inhibitors: Alternative of Natural Products for the Therapeutic Treatment of Alzheimer's Disease
In silico study of β-carboline alkaloids as Acetylcholinesterase Inhibitors: Alternative of Natural Products for the Therapeutic Treatment of Alzheimer's Disease
-
DOI: https://doi.org/10.22533/at.ed.1594872424098
-
Palavras-chave: acetilcolinesterase, β-carboliníco, alcaloides, docking molecular
-
Keywords: acetylcholinesterase, β-carboline, alkaloids, molecular docking.
-
Abstract: Alzheimer's disease is a neurodegenerative disease that mainly affects the elderly population. The cholinergic hypothesis is based on the decrease in the synthesis of the neurotransmitter acetylcholine, compromising the cholinergic function. Thus, a therapeutic strategy adopted for this hypothesis is the use of drugs that inhibit acetylcholinesterase, increasing acetylcholine levels, favoring neurotransmission. The present work aimed to study β-carboline alkaloids as acetylcholinesterase inhibitors, through molecular docking studies and analysis of their ADME/Tox properties. For this, 92 alkaloids from 14 different subclasses were analyzed. Among them, alkaloid penipaline B showed important interactions with the peripheral anionic subsite of AChE, evidenced by docking studies. The data obtained indicate that the alkaloid penipaline B is the most promising inhibitor among the studied ligands due to its important interactions with the protein and its ADME/Tox properties.
- Luiz F. B. da Silva,
- BUANA CARVALHO DE ALMEIDA
- Bartholomeu A. B. Filho,
- Daniel G. Silva
- Buana C. de Almeida